HealthCare Global Enterprises (HCG) has begun treating cancer patients using Karnataka’s first Elekta Unity MR-Linac, making MR-guided adaptive radiation therapy available in the state. The technology brings one of the most advanced forms of radiation treatment to patients across Karnataka and neighbouring regions.
Real-Time Imaging Improves Treatment Precision
The Elekta Unity combines a 1.5 Tesla MRI scanner with a linear accelerator, enabling clinicians to visualise tumours and surrounding anatomy in real time. Consequently, doctors can modify the treatment plan during each session to match anatomical changes, delivering highly precise radiation while protecting healthy tissue.
India’s growing cancer burden underscores the need for advanced treatment options. According to the Global Cancer Observatory (GLOBOCAN), new cancer cases in the country are expected to reach 2.08 million by 2040, a 57.5% increase from 2020. As per the press release, MR-guided adaptive radiation therapy offers more personalised treatment by adapting radiation delivery to a patient’s anatomy each day.
Leaders Emphasise Better Patient Outcomes
Dr. B.S. Ajaikumar, Founder and Chairman of HCG, said the Unity MR-Linac marks another milestone in precision medicine by enabling highly targeted radiation with minimal exposure to healthy tissue, helping improve outcomes while reducing side effects.
Dr. Manish Mattoo, Executive Director and CEO of HCG, said the technology combines real-time imaging with adaptive treatment planning to deliver personalised care and expand access to advanced cancer treatment across the region.
Elekta leaders Feras Al Hasan and Dr. John P. Christodouleas highlighted that the partnership with HCG will accelerate the adoption of adaptive radiotherapy in India through advanced technology, training, and clinical collaboration.
Advancing Precision Cancer Care
The new MR-Linac is particularly valuable for treating tumours located near critical organs or in areas where anatomy changes during therapy. The launch marks another step towards expanding access to world-class precision radiation therapy and improving cancer care outcomes in India.